Crossing the line? As Obama clears path for embryonic stem-cell research, Catholic healthcare finds itself at crossroads of religion and medicine.
With the reversal of limits on stem-cell research, Roman Catholic hospitals may find themselves left behind in a medical revolution because of their rejection of the science. But others are eager to join in. "Researchers will now be able to pursue new knowledge about human development, regenerative medicine and the origins of many of our most devastating diseases," said Lawrence Tabak, left, the NIH acting deputy director.